Kefeng Ding

34PUBLICATIONS
106CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer cell biologyPredictive and prognostic markersPolymers and plastics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Aug 31, 2026
First-line anlotinib versus bevacizumab plus CapeOX in RAS/BRAF wild-type unresectable metastatic colorectal cancer (ANCHOR): a multicenter, prospective, randomized, phase 3 trial.

|Aug 27, 2026
Low SLC8A1 in Colorectal Cancer Dictates Radiotherapy Resistance Through Calcium-Dependent ANXA2+sEVs Driving M2 Polarization of TAMs.

|Jul 24, 2026
Dynamic regulation of lysine and arginine metabolism promotes immune evasion by limiting T cell function in cancer.

|Mar 12, 2026
BEX2 influences the MCL1-Hedgehog signaling axis to regulate the potential of stemness characterization in colorectal cancer.

Yucheng Qian, Jingsun Wei, Yuan Bian

|Feb 18, 2026
Efficacy and safety of tislelizumab as neoadjuvant treatment in patients with stage II-III microsatellite instability-high/mismatch repair-deficient colorectal cancer: a single-arm, multicenter, open-label, prospective, phase II study.

Gong Chen, Yao Ye, Yue Liu

|Dec 26, 2025
Prognostic Factors and Nomogram-Based Prediction Models for Colorectal Cancer Patients With Synchronous Peritoneal Metastasis Undergoing Cytoreductive Surgery: A Retrospective Cohort Study.

Xiaoxu Ge, Guanli Yang, Huiming Wu

Pageof 6

Frequent Collaborators

7 joint publications

Qian Xiao

5 joint publications

Xue Li

4 joint publications

Ying Yuan

4 joint publications

Yeting Hu